In ₹ Crore except Per Share Latest Annual	ORCHPHARMA FY26	FDC FY26	GUJTHEM FY26	IOLCP FY26	Peer Average
Valuation — at last close
P/E	521.08×	◆ 21.78×	83.07×	38.51×	47.79× +990%
P/B	3.31×	◆ 2.47×	13.46×	2.95×	6.29× -47%
EV/EBITDA	160.78×	◆ 16.20×	53.33×	19.45×	29.66× +442%
Market Cap	₹5,180 Cr	₹6,131 Cr	₹3,874 Cr	₹5,302 Cr	₹5,102 Cr +2%
Growth
Revenue CAGR 3Y	◆ 22.79%	6.77%	—	1.51%	4.14% +450%
Revenue CAGR 5Y	◆ 22.33%	10.24%	—	—	10.24% +118%
Net Income CAGR 3Y	-40.09%	◆ 13.23%	—	-0.36%	6.44% -723%
Revenue YoY (latest Q)	◆ 75.89%	20.95%	22.07%	37.08%	26.70% +184%
Net Income YoY (latest Q)	-78.38%	72.92%	22.12%	◆ 89.80%	61.61% -227%
Profitability
EBITDA Margin	2.72%	15.94%	◆ 45.55%	11.60%	24.36% -89%
Net Income Margin	0.81%	12.96%	◆ 28.15%	5.94%	15.68% -95%
Return on Common Equity	0.70%	11.81%	◆ 17.41%	7.90%	12.37% -94%
Return on Capital Employed	-0.61%	11.69%	◆ 17.76%	10.29%	13.25% -105%
Return on Assets	0.50%	9.99%	◆ 11.60%	5.54%	9.04% -94%
Credit & Quality
Total Debt/Equity	0.19×	◆ 0.00×	0.56×	0.07×	0.21× -10%
Interest Coverage	-1.08×	◆ 57.54×	21.23×	12.97×	30.58× -104%
Scale — latest FY
Revenue / Total Income	₹1,233 Cr	₹2,171 Cr	₹166 Cr	₹2,319 Cr	₹1,552 Cr -21%
Net Income	₹10 Cr	₹281 Cr	₹46.7 Cr	₹138 Cr	₹155 Cr -94%
Total Assets	₹2,258 Cr	₹2,919 Cr	₹503 Cr	₹2,587 Cr	₹2,003 Cr +13%
EPS	₹1.66	₹17.29	₹4.28	₹4.69	₹8.75 -81%
Book Value per Share	₹261.22	₹152.64	₹26.41	₹61.27	₹80.11 +226%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.